Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesNortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial
The Lancet - Early Online Publication, 10/01/09
Gilron I et al. – Combined gabapentin and nortriptyline seems to be more efficacious than either drug given alone for neuropathic pain, therefore the authors recommend use of this combination in patients who show a partial response to either drug given alone and seek additional pain relief. Future trials should compare other combinations to their respective monotherapies for treatment of such pain.
Related Articles
Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial
The Lancet, 10/13/09
Relevance Score: 85%
Popular Antidepressant Associated With A Dramatic Increase In Suicidal Thoughts Amongst Men, Study Finds
ScienceDaily, 10/16/09
Relevance Score: 80%
Drug Combo May Offer Best Relief for Nerve Pain
MedLinePlus, 10/01/09
Relevance Score: 80%
Today in Neuro/Psych pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Durability of Therapeutic Response to Milnacipran Treatment for Fibromyalgia. Results of a Randomized, Double-Blind, Monotherapy 6-Month Extension Study
Pain Medicine, 12/10/09
An Open Pilot Study Assessing the Benefits of Quetiapine for the Prevention of Migraine Refractory to the Combination of Atenolol, Nortriptyline, and Flunarizine
Pain Medicine, 12/10/09
Depression in Parkinson's Disease
Canadian Journal of Neurological Sciences, 12/09/09
Sponsor
Article Search
Sponsor